Norberg B, Nilsson T K
Department of Internal Medicine, University Hospital, Umeå, Sweden.
Acta Med Scand. 1987;222(5):459-64. doi: 10.1111/j.0954-6820.1987.tb10965.x.
A retrospective analysis of evidence of platelet clumping, an in vitro phenomenon in blood samples anticoagulated by EDTA, was performed in 49 patients with myeloproliferative diseases other than chronic myeloid leukaemia. Evidence of platelet clumping was provided by the H6000 picture, which in the presence of platelet aggregates yields a characteristic "whisk" in a defined region. Out of the 49 patients, 17 (35%) had evidence of platelet clumping which, however, occurred in an unpredictable manner from time to time. Platelet clumping thus provides a confounding factor when automated platelet counts are used to monitor effects of cytotoxic treatment in this type of disorders. In a prospective study, it was shown that the problem can be overcome by optimizing the hospital routine to secure minimum delay between sampling and analysis.
对49例慢性髓性白血病以外的骨髓增殖性疾病患者进行回顾性分析,以研究血小板聚集这一在乙二胺四乙酸(EDTA)抗凝血样中的体外现象的证据。血小板聚集的证据由H6000图像提供,在存在血小板聚集体的情况下,该图像在特定区域会产生特征性的“须状物”。49例患者中,17例(35%)有血小板聚集的证据,然而,其发生时间不可预测。因此,当使用自动血小板计数来监测此类疾病的细胞毒性治疗效果时,血小板聚集成为一个混杂因素。在前瞻性研究中表明,通过优化医院常规流程以确保采样和分析之间的延迟最小,可以克服这个问题。